Maker of Wegovy cites heart benefits, which could pressure insurers to start covering
(Newser) -
A new study suggests the popular weight-loss drug Wegovy might cut the risk of heart disease as well. If the study is confirmed—and it hasn't yet been peer-reviewed—the results could pressure insurers to start covering the pricey drug, reports the New York Times . Maker Novo Nordisk charges...